Indirubin Core Structure of Glycogen Synthase Kinase-3 Inhibitors as Novel Chemotype for Intervention with 5-Lipoxygenase
Authors:
- Carlo PergolaCPCarlo Pergola
- Ulrike GarschaUGUlrike Garscha
- Christina WeinigelCWChristina Weinigel
- Dagmar BarzDBDagmar Barz
- Kai F. AlbringKAKai F. Albring
- Otmar HuberOHOtmar Huber
- 17 April 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 57 (9) , 3715-3723
Abstract
The enzymes 5-lipoxygenase (5-LO) and glycogen synthase kinase (GSK)-3 represent promising drug targets in inflammation. We made use of the bisindole core of indirubin, present in GSK-3 inhibitors, to innovatively target 5-LO at the ATP-binding site for the design of dual 5-LO/GSK-3 inhibitors. Evaluation of substituted indirubin derivatives led to the identification of (3Z)-6-bromo-3-[(3E)-3-hydroxyiminoindolin-2-ylidene]indolin-2-one (15) as a potent, direct, and reversible 5-LO inhibitor (IC50 = 1.5 μM), with comparable cellular effectiveness on 5-LO and GSK-3. Together, we present indirubins as novel chemotypes for the development of 5-LO inhibitors, the interference with the ATP-binding site as a novel strategy for 5-LO targeting, and dual 5-LO/GSK-3 inhibition as an unconventional and promising concept for anti-inflammatory intervention.Keywords
Funding Information
- European Commission (EU-FP7-REGPOT-2011-1, proposal 284460)
This publication has 37 references indexed in Scilit:
- Synthesis and Structure–Activity Relationship Studies of Novel Dual Inhibitors of Soluble Epoxide Hydrolase and 5-LipoxygenaseJournal of Medicinal Chemistry, 2013
- Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK KinasesACS Medicinal Chemistry Letters, 2012
- On the inhibition of 5‐lipoxygenase product formation by tryptanthrin: mechanistic studies and efficacy in vivoBritish Journal of Pharmacology, 2011
- Soluble 3′,6-Substituted Indirubins with Enhanced Selectivity toward Glycogen Synthase Kinase -3 Alter Circadian PeriodJournal of Medicinal Chemistry, 2008
- Novel and Potent Inhibitors of 5-Lipoxygenase Product Synthesis Based on the Structure of Pirinixic AcidJournal of Medicinal Chemistry, 2008
- The tumor suppressor Fhit acts as a repressor of β-catenin transcriptional activityProceedings of the National Academy of Sciences, 2007
- LeukotrienesNew England Journal of Medicine, 2007
- The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5‐lipoxygenase productsBritish Journal of Pharmacology, 2007
- Characterization of the arachidonate and ATP binding sites of human 5-lipoxygenase using photoaffinity labeling and enzyme immobilizationBiochemistry, 1995
- Improved purification of 12-lipoxygenase from rat basophilic leukemia cells and conditions for optimal enzyme activityBiochimica et Biophysica Acta (BBA) - General Subjects, 1991